Table 1 Patient characteristics

Age [y.o.]

Median [range]

63 [31, 95]

Mean ± SD

64 ± 12

Gender

Male

72 (71 %)

Female

30 (29 %)

Tumour site

Larynx

11 (11 %)

Hypopharynx

13 (13 %)

Oral Cavity

4 (4 %)

Oropharynx

48 (47 %)

Nasopharynx

22 (22 %)

Nasal/paranasal sinus

4 (4 %)

T stage

1

11 (11 %)

2

27 (26 %)

3

25 (25 %)

4

29 (28 %)

4a

9 (9 %)

4b

1 (%)

N stage

0

15 (15 %)

1

13 (13 %)

2

14 (14 %)

2a

4 (4 %)

2b

32 (31 %)

2c

18 (18 %)

3

5 (5 %)

3b

1 (1 %)

TNM stage

Stage 3

20 (20 %)

Stage 4a

56 (55 %)

Stage 4b

26 (25 %)

Histology

Squamocellular carcinoma

89 (87 %)

Undifferentiated carcinoma

12 (12 %)

Mucoepidermoid carcinoma

1 (1 %)

Performance Status

PS = 0

69 (68 %)

PS = 1

24 (23 %)

PS = 2

9 (9 %)

Induction Chemotherapy

No

47 (46 %)

TPF

47 (46 %)

CBCDA + 5FU

2 (2 %)

CBCDA + adriamicin

1 (1 %)

CDDP + 5FU

4 (4 %)

CDDP + adriamicin

1 (1 %)

Concomitant Chemotherapy

No

9 (9 %)

Cetuximab

19 (19 %)

Weekly Cisplatinum

64 (63 %)

Three-weekly Cisplatinum

10 (10 %)